Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

OBJECTIVE: To evaluate variables associated with hemoglobin A1c (HbA1c) and weight reduction when adding liraglutide to persons with type 2 diabetes treated with multiple daily insulin injections (MDI). RESEARCH DESIGN AND METHODS: This was a reanalysis of a previous trial where 124 patients were en...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlqvist, Sofia, Ahlén, Elsa, Filipsson, Karin, Gustafsson, Thomas, Hirsch, Irl B, Tuomilehto, Jaakko, Imberg, Henrik, Ahrén, Bo, Attvall, Stig, Lind, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Clinical Care/Education/Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841497/
https://www.ncbi.nlm.nih.gov/pubmed/29527308
http://dx.doi.org/10.1136/bmjdrc-2017-000464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841497/
https://www.ncbi.nlm.nih.gov/pubmed/29527308
http://dx.doi.org/10.1136/bmjdrc-2017-000464

Ejemplares similares